Inflammatory stimuli promote lipid accumulation in myelin-phagocytosing macrophages: effects of LXR, PPARγ and RXR agonists
This study demonstrates that inflammatory stimuli impair myelin clearance by promoting lipid accumulation in macrophages, a process that can be mitigated by agonists of the nuclear receptors LXR, PPARγ, and RXR, suggesting these receptors as potential therapeutic targets for CNS injuries involving lipid debris.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
When the spinal cord is injured, the damage does not stop at the moment of impact. The initial trauma triggers a cascade of secondary events, including a fierce inflammatory response that can prevent the body from healing. A major obstacle in this recovery process is the debris left behind by damaged nerve fibers. These fibers are wrapped in a fatty coating called myelin, which acts like insulation on an electrical wire. When nerves break, this myelin shatters into pieces. While the body's immune cells, specifically macrophages, are designed to clean up such debris, the myelin fragments are so rich in fat that they can overwhelm these cells. Instead of simply digesting the waste, the immune cells often become clogged with the fat, turning into sluggish, foam-like structures that block regeneration and keep the inflammation alive. Understanding how these cells process this fat, and what happens when the body is under inflammatory stress, is crucial for finding ways to help the nervous system recover.
Researchers at the Hospital Nacional de Parapléjicos in Toledo, Spain, set out to investigate exactly how inflammatory signals affect the way macrophages handle myelin debris. They focused on a specific question: when these immune cells are exposed to the chemical signals of inflammation, do they break down the myelin more efficiently, or do they struggle and store the fat instead? To answer this, the team used two types of cells: a well-known mouse cell line and bone marrow-derived macrophages, which are immune cells grown from mouse bone marrow to better mimic the cells found in a living body. They fed these cells myelin that had been labeled with a special dye, allowing them to track exactly how much myelin the cells swallowed and what happened to it over time.
The team observed that when macrophages were exposed to inflammatory signals, such as lipopolysaccharide or interferon-gamma, the cells did not clear the myelin as expected. Instead, the myelin accumulated inside them. In cells that were simply eating myelin, the researchers saw the internal signal of the myelin fade over forty-eight hours, indicating that the cells were successfully breaking it down. However, when inflammatory signals were added, that signal remained strong, suggesting the breakdown process had stalled. The cells were holding onto the debris rather than processing it. This accumulation was not just a matter of holding onto the myelin; the cells were also storing the fat derived from the myelin in tiny droplets inside themselves. By using a dye that lights up neutral fats, the researchers found that cells under inflammatory stress were packed with these lipid droplets, resembling the foam cells seen in clogged arteries.
The study revealed that this effect depended on the type of cell and the duration of the exposure. In the bone marrow-derived cells, which are considered a more accurate model for the human body, the inflammatory signals took longer to cause a buildup of fat, requiring forty-eight hours to show a significant increase. In contrast, the cell line showed this accumulation much faster, within twenty-four hours. This difference highlighted that the cell line might not fully capture the slower, more complex metabolic shifts seen in real immune cells. The researchers also noted that the cells physically changed shape and size as they filled with fat, becoming larger and more complex internally, which further confirmed that the inflammatory environment was reprogramming how these cells handled energy and waste.
To see if this clogging could be reversed, the team tested several compounds known to influence how cells manage fat. They treated the inflammatory, myelin-eating cells with agonists, which are molecules that activate specific receptors inside the cell. One compound, which activates a receptor called LXR, and another that activates a receptor called RXR, both succeeded in reducing the amount of fat stored in the cells. When these drugs were present, the cells held onto less lipid droplets, even while they were still exposed to inflammatory signals. A third compound, which activates a different receptor called PPARγ, had no effect. The results suggest that turning on the LXR or RXR pathways can help the cells clear the fat that inflammation causes them to hoard.
The findings point toward a potential strategy for treating spinal cord injuries. If the body's natural inflammatory response causes immune cells to become clogged with myelin fat, preventing them from cleaning the injury site, then using drugs that activate these specific nuclear receptors might help the cells clear the debris more effectively. The researchers propose that by reducing the accumulation of lipid droplets, these treatments could help the immune cells return to a healthier state, potentially removing the blockage that stops nerves from regrowing. While the study was conducted in a laboratory setting using mouse cells, it establishes a clear link between inflammation, fat storage in immune cells, and the failure to clear nerve debris, offering a new direction for therapeutic research.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.